OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase-I/II radio-immunotherapy study with iodine-131-labeled anti-CEA monoclonal antibody F6 F(ab′)2 in patients with non-resectable liver metastases from colorectal cancer

HTML

Year: 1998
Type: article
Study design: Clinical Trial
Source: International Journal of Cancer
DOI: 10.1002/(sici)1097-0215(19980209)75:4<615::aid-ijc20>3.0.co;2-6
Authors: Marc Ychou, André Pelegrin, Patrick Faurous, Bruno Robert, Jean-Claude Saccavini, Dominique Guerreau, Jean-François Rossi, Michel Fabbro, Franz Buchegger, Jean-Pierre Mach, Jean-Claude Artus
Institutions: University Hospital of Geneva, University of Lausanne
Language: English

Topic: Radiopharmaceutical Chemistry and Applications
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Keywords: radioimmunotherapy, iodine-131, F(ab')2 fragments, carcinoembryonic antigen, colorectal cancer, liver metastasis, maximum tolerated dose, hematologic toxicity, autologous bone marrow rescue, tumor uptake, single photon emission tomography, dose escalation, tumor response, non-resectable metastases
SDG: Good health and well-being

Open Access status: closed

Funder: Fondation Gustave et Simone Prévot
OpenAlex ID: W1989104087
FWCI: 6.717
Cites: 20
Cited by: 62
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security